Wang, Zhiren http://orcid.org/0000-0002-2016-0517
Li, Wenpan http://orcid.org/0000-0002-8546-7384
Jiang, Yanhao http://orcid.org/0009-0006-2403-0601
Tran, Tuyen Ba
Cordova, Leyla Estrella http://orcid.org/0009-0009-3992-7157
Chung, Jinha
Kim, Minhyeok http://orcid.org/0009-0007-0766-3869
Wondrak, Georg http://orcid.org/0000-0003-4799-8608
Erdrich, Jennifer http://orcid.org/0000-0003-0585-0402
Lu, Jianqin http://orcid.org/0000-0002-5877-619X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35GM147002, R01CA272487)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 27 February 2023
Accepted: 31 October 2023
First Online: 9 November 2023
Competing interests
: J.L. has applied for patents related to this technology (patent title: Immunogenic nanovesicles for cancer immunotherapy, patent number: WO2022115488). The remaining authors declare no competing interests.